JP Morgan Chase’s Fractyl Health GUTS Stock Holding History

JP Morgan Chase’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21K	Buy	127 +49	+63%	+$419	﹤0.01%	7301
2026 Q1	$399	Hold	78	–	–	﹤0.01%	7197
2025 Q4	$2.06K	Sell	78 -4,151	-98%	-$80.2K	﹤0.01%	6940
2025 Q3	$80.7K	Buy	+4,229	New	+$65.8K	﹤0.01%	6026
2025 Q2	–	Sell	-1,425	Closed	-$20.3K	–	7730
2025 Q1	$20.3K	Buy	1,425 +94	+7%	+$1.8K	﹤0.01%	6148
2024 Q4	$32.9K	Buy	1,331 +97	+8%	+$2.71K	﹤0.01%	6136
2024 Q3	$37.5K	Buy	1,234 +951	+336%	+$37.2K	﹤0.01%	6078
2024 Q2	$14.5K	Sell	283 -2,947	-91%	-$228K	﹤0.01%	6199
2024 Q1	$287K	Buy	+3,230	New	+$326K	﹤0.01%	5130

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase's GUTS Position: Q2 2026 in Review

JP Morgan Chase increased its Fractyl Health (GUTS) stake by 63% in Q2 2026, buying an estimated $419 and bringing the position to 127 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #7301.

JP Morgan Chase first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $287K in Q1 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

JP Morgan Chase held 127 shares of Fractyl Health worth $1.21K as of Q2 2026.
JP Morgan Chase bought 49 Fractyl Health shares in Q2 2026, an estimated $419.
Fractyl Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7301 holding.
JP Morgan Chase first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
JP Morgan Chase's Fractyl Health position peaked at $287K in Q1 2024.
77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.